Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Chronic Heart Failure

  Free Subscription


1 Am J Cardiol
3 Circulation
1 Eur Heart J
12 Eur J Heart Fail
3 Int J Cardiol
1 N Engl J Med
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Cardiol

  1. PAIVA L, Vieira MJ, Simoes M, Ferreira MJ, et al
    Unstable Angina Risk Stratification using High-sensitivity Cardiac Troponin and Coronary Angiography.
    Am J Cardiol. 2024 Apr 3:S0002-9149(24)00233.
    PubMed         Abstract available


  2. AMDANI S, Conway J, George K, Martinez HR, et al
    Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2024 May 29. doi: 10.1161/CIR.0000000000001245.
    PubMed         Abstract available

  3. JHENG JR, Bai Y, Noda K, Huot JR, et al
    Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction.
    Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.124.068624.
    PubMed         Abstract available

  4. CALLER T, Rotem I, Shaihov-Teper O, Lendengolts D, et al
    Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.
    Circulation. 2024;149:1729-1748.
    PubMed         Abstract available

    Eur Heart J

  5. PACKER M, Cleland JGF, Bauersachs J
    Great Debate: SGLT2 inhibitors should be first-line treatment in heart failure with reduced ejection fraction.
    Eur Heart J. 2024 May 28:ehae300. doi: 10.1093.

    Eur J Heart Fail

  6. FUDIM M, Dalgaard F, Friedman DJ, Abraham WT, et al
    Comorbidities and clinical response to cardiac resynchronization therapy: Patient-level meta-analysis from eight clinical trials.
    Eur J Heart Fail. 2024;26:1039-1046.
    PubMed         Abstract available

  7. RASTOGI T, Ferreira JP, Butler J, Kraus BJ, et al
    Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved.
    Eur J Heart Fail. 2024;26:885-896.
    PubMed         Abstract available

  8. TANAKA T, Sugiura A, Kavsur R, Ozturk C, et al
    Changes in right ventricular function and clinical outcomes following tricuspid transcatheter edge-to-edge repair.
    Eur J Heart Fail. 2024;26:1015-1024.
    PubMed         Abstract available

  9. KERAMIDA K, Yang EH, Deswal A
    Moving theory and reality closer together in cardio-oncology training.
    Eur J Heart Fail. 2024;26:772-775.

  10. SATTAR N, Butler J, Lee MMY, Harrington J, et al
    Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trial.
    Eur J Heart Fail. 2024;26:900-909.
    PubMed         Abstract available

  11. D'AMARIO D, Laborante R, Santangeli P
    Comorbidities and cardiac resynchronization therapy: Do we talk the talk or should we walk the walk?
    Eur J Heart Fail. 2024;26:1047-1050.

    Sodium-glucose cotransporter 2 inhibitors and skeletal muscle.
    Eur J Heart Fail. 2024;26:936-937.

  13. ROMMEL KP, Bonnet G, Fortmeier V, Stolz L, et al
    Congestion patterns in severe tricuspid regurgitation and transcatheter treatment: Insights from a multicentre registry.
    Eur J Heart Fail. 2024;26:1004-1014.
    PubMed         Abstract available

  14. PATEL N, Yeboah J
    Multimorbidity in the era of increasing life expectancy and aging population.
    Eur J Heart Fail. 2024;26:869-870.

  15. PABON MA, Vaduganathan M, Lam CSP
    Is the optimal dose of heart failure medical therapy different in women and men?
    Eur J Heart Fail. 2024 May 27. doi: 10.1002/ejhf.3320.

  16. PAGNESI M, Serafini L, Chiarito M, Stolfo D, et al
    Impact of malnutrition in patients with severe heart failure.
    Eur J Heart Fail. 2024 May 29. doi: 10.1002/ejhf.3285.
    PubMed         Abstract available

  17. CISNEROS-BARROSO E, Rossello X
    Sodium-glucose cotransporter 2 inhibitors in acute and chronic coronary syndrome with and without heart failure.
    Eur J Heart Fail. 2024 May 29. doi: 10.1002/ejhf.3321.

    Int J Cardiol

  18. ANSARI RAMANDI MM, Hendriks PM, Voors AA, van den Bosch AE, et al
    Bioactive adrenomedullin as a marker of congestion and disease progression in patients with a systemic right ventricle.
    Int J Cardiol. 2024;408:132107.
    PubMed         Abstract available

  19. TADA A, Nagai T, Anzai T
    Is growth differentiation factor-15 a useful biomarker for chronic heart failure across body size?
    Int J Cardiol. 2024 May 23:132204. doi: 10.1016/j.ijcard.2024.132204.

  20. LEE S, Battumur B, Lee JE, Park SH, et al
    Assessing lung fluid status using noninvasive bioelectrical impedance analysis in patients with acute heart failure: A pilot study.
    Int J Cardiol. 2024;409:132205.
    PubMed         Abstract available

    N Engl J Med

  21. HERRMANN HC, Mehran R, Blackman DJ, Bailey S, et al
    Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus.
    N Engl J Med. 2024 Apr 7. doi: 10.1056/NEJMoa2312573.
    PubMed         Abstract available

    PLoS One

  22. SHEARER JJ, Hashemian M, Nelson RG, Looker HC, et al
    Demographic trends of cardiorenal and heart failure deaths in the United States, 2011-2020.
    PLoS One. 2024;19:e0302203.
    PubMed         Abstract available

  23. LIU W, Lin Q, Fan Z, Cui J, et al
    Major depression disorder and heart failure: A two-sample bidirectional Mendelian randomization study.
    PLoS One. 2024;19:e0304379.
    PubMed         Abstract available

  24. ZHOU Y, Zhao Q, Liu Z, Gao W, et al
    Blood urea nitrogen/creatinine ratio in heart failure: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0303870.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.